In a shocking expose, it’s clear that organ transplants, while a remarkable breakthrough in modern medicine, are also tainted by a corrupt and profit-driven system that prioritizes financial gain over human life. Behind the heartwarming stories of lives saved, a dark reality exists, where the pursuit of profit leads to unethical practices, putting vulnerable individuals at risk of exploitation. The organ donation system, a multibillion-dollar industry, is marred by a web of deceit, where the concept of “brain death” is often misused, and hospitals are accused of rushing to harvest organs from people who may still be clinging to life. Furthermore, grieving families are often coerced into giving consent, unaware of the true nature of the system. As we delve deeper into the underbelly of the organ donation system, it becomes clear that the very foundations of this life-saving practice are tainted by corruption, greed, and a blatant disregard for human life. The question remains, how can we trust a system that is driven by profit, rather than a genuine desire to save lives and improve the human condition?

The Harsh Reality of Organ Transplants

Federal investigators are blowing the lid off a shocking scandal, revealing that a staggering 30% of organ donors are still showing signs of life as surgeons prepare to harvest their organs. Nurses are coming forward to expose the disturbing truth that some donors are being sedated or paralyzed to make the process easier and more convenient for medical professionals. The alarming reality is that the definition of “death” was redefined decades ago, paving the way for this nightmare to unfold. While organ transplants do have the power to save lives, the system is undeniably corrupt, with patients being misdiagnosed as “brain dead” and displaying signs of life just as their organs are about to be harvested. The organ trade has ballooned into a billion-dollar industry, with transplants costing upwards of $2 million, creating a lucrative market that invites exploitation. Estimates suggest that a staggering 5-20% of kidney transplants are sourced from the black market, preying on the poor and imprisoned. Perhaps the most shocking truth of all is that the definition of death was deliberately redefined to facilitate easier organ harvesting. It was back in 1968 that Harvard introduced the concept of “brain death,” allowing for the legal harvesting of organs from individuals with beating hearts. Since then, numerous patients diagnosed as brain dead have miraculously revived, sometimes just moments before their organs were scheduled to be removed. This is not the stuff of conspiracy theories – it’s a harsh and disturbing reality that’s happening to real people who have lived to tell their stories. At the heart of the issue is a system that prioritizes profits over human lives, leaving countless individuals to suffer the consequences.

The Billion-Dollar Cash Cow: Profits Over Patients

The global organ transplantation market is set to explode from $19.21 billion in 2025 to a whopping $39.19 billion by 2034, with the US market alone expected to double from $4.18 billion in 2023 to $9.58 billion by 2032. This booming industry is fueled by the desperation of people who can’t afford life-saving transplants, leaving them with no choice but to rack up medical debt or rely on government programs like Medicare, which are funded by taxpayers. The cost of a single organ transplant is staggering, ranging from $2 million to over $3 million, with kidney transplants costing around $446,800, heart transplants reaching up to $1.66 million, liver transplants costing approximately $878,400, and double lung transplants hitting a staggering $1.3 million. And it’s not just a one-time payment – patients have to take expensive immunosuppressant drugs for the rest of their lives to prevent rejection, which are sold by pharmaceutical giants like Pfizer and Novartis at outrageous prices. The kidney transplant medicine market is projected to surge from $12.84 billion in 2025 to $19.09 billion by 2032, forcing patients to rely on these pricey medications forever.

From a financial standpoint, this is a clear case of cronyism, where a handful of organ procurement organizations and the United Network for Organ Sharing have been given a government-backed monopoly on coordinating donations, pocketing federal funds while lobbying against reforms that could bring in real competition and lower costs. This system is rigged against taxpayers, who are subsidizing the waste and inefficiencies of the system. Organ procurement organizations are paid per organ procured, creating incentives to cut corners and prioritize profits over people. Federal investigations have uncovered widespread fraud, with at least five states’ organizations under investigation for overbilling and intimidating whistleblowers. A shocking report from the Department of Health and Human Services in 2025 exposed a “systemic disregard for the sanctity of life,” with hospitals rushing to procure organs even when patients showed signs of life. Nearly 20% of transplants last year bypassed waiting lists altogether, with organs being handed to the well-connected instead of those in dire need. This is a clear example of a system that prioritizes profits over patients, with the organ transplantation market being a lucrative industry built on the desperation of individuals.

The Chilling Reality of “Brain Death” Misdiagnoses: Harvesting the Living?

The “Brain Death” Myth: Not Dead Yet, But Organs Up for Grabs

Let’s blow the lid off the myth that “brain death” is a hard medical fact. The truth is, a Harvard committee concocted this concept back in 1968, not to save lives, but to tackle the organ shortage that came after the first heart transplant. Before this, death was straightforward – it was when the heart stopped beating. But now, doctors are declaring patients “brain dead” even when their heart is still pumping, their body is warm, and their organs are fresh and ready for transplant. The real reason behind this is jaw-dropping: dead organs are useless for transplant, and a living body is needed to keep the organs alive and viable for a successful transplant.

This scandal is unfolding as patients declared “brain dead” reportedly astonishingly showing signs of life. In a chilling 2021 incident in Kentucky, Anthony Thomas “TJ” Hoover II was rushed into surgery to harvest his organs after a overdose – but he suddenly started thrashing, crying, and breathing on his own, forcing doctors to abruptly halt the operation. What’s even more disturbing is that TJ’s sister, Donna Rhorer, had already discovered he had regained consciousness during a heart test that morning, yet the organ procurement team still pushed forward with the surgery. A federal probe into this matter found some alarming stats – out of 351 cases reviewed, 103 raised serious concerns, including 73 instances where patients showed brain activity and at least 28 cases where patients may have been alive when the surgery started. Another jaw-dropping case is that of Misty Hawkins, a 42-year-old Alabama woman who fell into a coma after choking on her lunch. After being off the ventilator for 103 minutes, she was declared dead and surgeons began the operation – only to find her heart still beating, and she gasped and moved, raising serious questions about whether she was declared dead too soon. In California, a father’s desperate fight to save his daughter Brittany O’Connor from being declared “brain dead” was prolonged because the hospital was pushing for organ donation despite doubts about her condition. This is not just a case of careless medicine – it’s a deep-seated, systemic issue that’s putting lives at risk.

Nonprofit organ procurement groups, backed by federal contracts, are feeling the heat to hit their targets – and rural hospitals are the easiest targets due to their limited resources and vulnerability to manipulation. The pharmaceutical industry is cashing in big time on this system, as a steady supply of fresh organs means more transplants, higher success rates, and a constant need for immunosuppressant meds, generating a lifetime of revenue.

Hospitals are basically playing God, putting profits over people’s lives. RFK Jr., the new head of HHS, is calling out this disturbing trend: medical staff are inducing comas, intubating patients, letting infections take hold, and then giving up on them – all so they can harvest organs for cash. This is essentially a form of stealth euthanasia, masked as kindness. We can’t let the government and medical bigwigs get away with redefining death to line their pockets.

Written By Tatenda Belle Panashe

]]> https://ln24international.com/2025/10/22/the-truth-about-organ-donations-and-transplants/feed/ 0 https://ln24international.com/2025/05/08/the-big-business-of-oncology-and-chemotherapy/?utm_source=rss&utm_medium=rss&utm_campaign=the-big-business-of-oncology-and-chemotherapy https://ln24international.com/2025/05/08/the-big-business-of-oncology-and-chemotherapy/#respond Thu, 08 May 2025 08:35:30 +0000 https://ln24international.com/?p=24133 In 2015, Dr. Farid Fata, a Michigan oncologist, was sentenced to 45 years in prison for a massive healthcare fraud scheme. Fata falsely diagnosed over 550 patients with cancer or misled them about the severity of their condition, administering unnecessary chemotherapy and other treatments to defraud Medicare and private insurers of approximately $34 million. He also received kickbacks from hospice and home healthcare services for patient referrals and was ordered to forfeit $17.6 million. His actions caused severe physical and emotional harm, with patients suffering from painful treatments, organ damage, and lasting trauma. Whistleblowers, including an office manager and a nurse, exposed the fraud, leading to his 2013 arrest. Fata pleaded guilty to 13 counts of healthcare fraud, one count of conspiracy to pay or receive kickbacks, and two counts of money laundering

Cancer has become an enormous business

The cancer industry is now a massive $222 billion market, driven by an unrelenting quest for profit that often prioritizes financial gains over patient welfare. This multibillion-dollar industry is fuelled by greed, with many players putting profits ahead of developing and sharing effective treatments, which perpetuates a culture of exploitation. Meanwhile, a deliberate effort is being made to suppress and conceal real cures and breakthroughs, resulting in prolonged and unnecessary suffering for millions of people worldwide who are bravely fighting this devastating disease.

The Food is Poisoned for Profit and Pharma Profits Off Illness

The food system is actively driving a vicious cycle, where the widespread consumption of processed foods is directly linked to a heightened risk of developing devastating health issues, including cancer. By flooding the market with these products, the food industry is inadvertently creating an environment that breeds disease, forcing individuals to undergo expensive and often invasive treatments, rather than providing effective solutions that tackle the root causes of these health problems head-on.

Cancer is Symptom of Toxins in the Body

Cancer is not just a disease, it’s a sophisticated physiological response to toxic substances invading the bloodstream, where the body’s defense mechanisms kick in to fight off the harmful effects of these toxins. In this scenario, a tumor can be seen as a deliberate self-protective mechanism, where the body intentionally encapsulates and isolates these toxic substances to prevent them from damaging surrounding tissues. However, when doctors perform a biopsy, they effectively breach this protective barrier, unleashing a flood of toxins back into the system, which can have catastrophic consequences. Essentially, this medical procedure doesn’t solve the underlying problem, it makes it worse, allowing toxins to spread and potentially triggering a chain reaction of devastating effects throughout the body.

How Big Pharma Controls Medical Schools

Radiation therapy hits the body with a powerful blow, siphoning off vital energy that would normally fuel the natural healing process and redirecting it to attack the cancerous tumor. Meanwhile, chemotherapy pours toxic chemicals into the body, throwing the entire physiological balance into chaos. This one-two punch doesn’t just weaken the immune system, making it more susceptible to new threats, but it also creates a breeding ground for new tumors to emerge, trapping patients in a vicious cycle of endless treatment and recurring illness. Doctors are now taking a closer look at the devastating impact of these treatments, and the shocking truth is that they can be just as deadly as the diseases they’re meant to cure. The harsh reality is that these therapies can have a crippling effect on the body, leaving patients to suffer from a multitude of debilitating side effects, from crippling fatigue to excruciating pain. As researchers dig deeper, they’re uncovering the alarming consequences of these treatments, and the findings are forcing a reckoning with the very foundations of modern medicine.

Every year, pharmaceutical companies shell out tens of millions of dollars to a significant number of cancer specialists, particularly those in academic positions, who are then tasked with creating guidelines that push the very same drugs they’re being paid to promote. These medical professionals are actively drafting and prescribing treatment plans to patients who are seeking unbiased advice, but instead, they’re serving up biased recommendations. A staggering 85% of the individuals responsible for writing the National Comprehensive Cancer Network guidelines have taken payments from pharmaceutical companies, and these corporations are pouring massive amounts of money into professional organizations. The American Society of Clinical Oncology’s annual convention, which is supposed to be a neutral forum for evaluating scientific data, has turned into a full-blown marketing extravaganza for the pharmaceutical industry, with the organization itself being heavily swayed by the massive influx of pharmaceutical funds.

How Big Pharma Pays Doctors to Push Chemotherapy

Reportedly, the human body actively responds to carcinogenic toxins in the bloodstream by encapsulating them in tumorous growths, effectively creating a containment vessel to isolate these hazardous substances. When medical professionals perform a biopsy, they directly breach this carefully constructed barrier, releasing toxic matter back into the bloodstream and potentially worsening the underlying condition. Moreover, administering radiotherapy can induce a state of systemic shock, diverting the body’s energy reserves away from the critical task of tumour degradation and towards crisis management, thereby undermining the body’s natural defences. At the same time, chemotherapy, although intended to target malignant cells, ultimately proves to be a blunt instrument, as it poisons the entire body and contaminates the bloodstream, which can trigger a perverse response, prompting the body to generate even more tumorous growths in a desperate bid for self-preservation.

Oncology is big business

Investigations reveal that the global cancer treatment market has skyrocketed to a staggering $158 billion in 2020, with experts predicting a massive surge to $268 billion by 2026. These alarming numbers demand a hard-hitting examination of the shocking lack of effective cures, fueling heated debates and intense scrutiny. The brutal truth is that the cancer industry is raking in billions of dollars from the suffering of patients, with projected growth expected to propel the market to a staggering $470 billion by 2032. As the medical sector faces explosive allegations of corruption, recent high-profile scandals have ignited widespread outrage and demands for accountability. We must launch a thorough and unflinching investigation into the cancer industry, re-examining the prevailing narrative and considering the disturbing possibility that it may be one of the most shocking deceptions of our time, driven by greed and corruption.

As the 20th century gave way to the 21st, the field of oncology was rocked by a slew of corrupt clinical trials, marked by shoddy control groups, subpar post-trial care, and blatant crossover practices that lined corporate pockets while leaving patients high and dry. Cancer specialists were allegedly on the take, pocketing payments from these companies and peddling a narrative that put profits ahead of people. The sheer scale of corruption and decay that had taken hold of this system had become so entrenched that it was almost impossible to see its inherent toxicity. Historians will likely view this era as a bleak period in the history of medicine, one in which dubious medications were pushed on terminally ill patients, while governments taxed struggling citizens to subsidize these ineffective treatments. Meanwhile, doctors, in the pocket of corporate interests, were complicit in promoting these products, even as the United States careened towards bankruptcy due to the staggering costs of misguided, harmful, and useless care. We must confront the severity of this crisis head-on and acknowledge that awareness is the first step towards driving real change. The medical community has a profound obligation to put genuine healing and patient welfare above financial gain, and it’s crucial that we reexamine our approach to cancer treatment, demanding greater transparency and accountability from the individuals and corporations that wield significant influence over this industry. Ultimately, it’s only through a collective effort to reform this broken system that we can create a more just and equitable healthcare landscape, one that puts patient well-being above all else.

Written By Tatenda Belle Panashe